Effectiveness and safety of low‐dose apatinib in advanced gastric cancer: A real‐world study

Effectiveness and safety of low‐dose apatinib in advanced gastric cancer: A real‐world study

Abstract Apatinib has been demonstrated to be effective and safe among patients with gastric cancer failing after at least two lines chemotherapy. This study aimed to evaluate its effectiveness and safety of low‐dose apatinib for the treatment of gastric cancer in real‐world practice. We performed a...

Full description

Bibliographic Details
Main Authors:	Yingying Du, Qisheng Cao, Congqiao Jiang, Hui Liang, Zhongliang Ning, Chushu Ji, Jinguo Wang, Chaoping Zhou, Zonghui Jiang, Changjun Yu, Lei Li, Yong Zhao, Yuemei Xu, Tengyun Xu, Wenjun Hu, Daoqin Wang, Huaidong Cheng, Guihe Wang, Jinhua Zhou, Song Wang, Yanshun Zhang, Zhiqiang Hu, Xinzhong Li, Donghui Lu, Jun Zhang, Hua Xie, Guoping Sun
Format:	Article
Language:	English
Published:	Wiley 2020-07-01
Series:	Cancer Medicine
Subjects:	advanced gastric cancer apatinib real‐world
Online Access:	https://doi.org/10.1002/cam4.3105

Similar Items

Research Progress on Antitumor Mechanism of Apatinib
by: ZHAO Lingying, et al.
Published: (2021-01-01)

Efficacy and Safety of Apatinib in the Treatment of Postoperative Recurrence of Fibrosarcoma
by: Ma H, et al.
Published: (2020-02-01)

Experimental study of the vascular normalization window for tumors treated with apatinib and the efficacy of sequential chemotherapy with apatinib in lung cancer‐bearing mice and patients
by: Mingtao Liu, et al.
Published: (2020-04-01)

Apatinib in the treatment of advanced lung adenocarcinoma with KRAS mutation
by: Zeng D, et al.
Published: (2017-08-01)

Research Progress of Combination Therapy of Apatinib on Tumor
by: WU Shan, et al.
Published: (2019-03-01)

Apatinib enhances chemosensitivity of gastric cancer to paclitaxel and 5-fluorouracil
by: Xu Z, et al.
Published: (2019-05-01)

Therapeutic Effect of Apatinib in First-line Treatment of Advanced Liver Cancer
by: KE Shaobo, et al.
Published: (2021-07-01)

Progress of Apatinib in Treatment of Non-small Cell Lung Cancer
by: LIANG Lijun, et al.
Published: (2018-11-01)

Anorexia, Hypertension, Pneumothorax, and Hypothyroidism: Potential Signs of Improved Clinical Outcome Following Apatinib in Advanced Osteosarcoma
by: Xie L, et al.
Published: (2020-01-01)

The effect of apatinib combined with chemotherapy or targeted therapy on non‐small cell lung cancer in vitro and vivo
by: Mingtao Liu, et al.
Published: (2019-10-01)

Apatinib inhibits tumor growth and angiogenesis in PNET models
by: Shan Wu, et al.
Published: (2019-01-01)

Apatinib mesylate tablet in the treatment of advanced malignant melanoma
by: Yang L, et al.
Published: (2018-08-01)

Efficacy and Safety of Apatinib in Treatment of Unresectable Intrahepatic Cholangiocarcinoma: An Observational Study
by: Hu Y, et al.
Published: (2020-07-01)

Apatinib Combined With SOX Regimen in Conversion Treatment of Advanced Gastric Cancer: A Case Series and Literature Review
by: Dingyi Jiang, et al.
Published: (2020-07-01)

Effect of Apatinib on Invasion and Migration of Lung Cancer Cells and Its Mechanism
by: Yin YUAN, et al.
Published: (2019-05-01)

A Study Of Efficacy And Safety With Apatinib Or Apatinib Combined With Chemotherapy In Recurrent/advanced Ovarian Cancer Patients
by: Yang M, et al.
Published: (2019-10-01)

Apatinib for patients with advanced or recurrent cervical cancer: study protocol for an open-label randomized controlled trial
by: Jian-Guo Zhou, et al.
Published: (2018-09-01)

Concurrent apatinib and docetaxel vs apatinib monotherapy as third- or subsequent-line therapy for advanced gastric adenocarcinoma: a retrospective study
by: Lin H, et al.
Published: (2019-02-01)

Efficacy and safety of apatinib treatment for advanced esophageal squamous cell carcinoma
by: Li J, et al.
Published: (2017-08-01)

Application effect of apatinib in patients with failure of standard treatment for advanced malignant tumours
by: Guohui Liu, et al.
Published: (2019-10-01)

Progress in the treatment of solid tumors with apatinib: a systematic review
by: Zhao D, et al.
Published: (2018-07-01)

Efficacy and Safety of Apatinib Treatment for Patients with Advanced Intrahepatic Cholangiocarcinoma
by: Lin G, et al.
Published: (2020-11-01)

Traditional Chinese medicine Astragalus polysaccharide enhanced antitumor effects of the angiogenesis inhibitor apatinib in pancreatic cancer cells on proliferation, invasiveness, and apoptosis
by: Wu J, et al.
Published: (2018-05-01)

Apatinib treatment is effective for metastatic malignant phyllodes tumors of the breast: a case report
by: Xiaolu Wang, et al.
Published: (2021-05-01)

Early presence of anti-angiogenesis-related adverse events as a potential biomarker of antitumor efficacy in metastatic gastric cancer patients treated with apatinib: a cohort study
by: Xinyang Liu, et al.
Published: (2017-09-01)

Apatinib treatment for KIT- and KDR-amplified angiosarcoma: a case report
by: Lishu Yang, et al.
Published: (2018-05-01)

Successful treatment with apatinib for refractory recurrent malignant gliomas: a case series
by: Zhang H, et al.
Published: (2017-02-01)

Efficacy and Safety of SBRT Combined With Camrelizumab and Apatinib in HCC Patients With PVTT: Study Protocol of a Randomized Controlled Trial
by: Yue Hu, et al.
Published: (2020-08-01)

Apatinib Plus Temozolomide for Recurrent Glioblastoma: An Uncontrolled, Open-Label Study
by: Wang Y, et al.
Published: (2019-12-01)

Reversible posterior leukoencephalopathy syndrome induced by apatinib: a case report and literature review
by: Li XT, et al.
Published: (2018-07-01)

The efficacy and safety of apatinib treatment for patients with advanced or recurrent biliary tract cancer: a retrospective study
by: Caiyun Nie, et al.
Published: (2021-02-01)

Apatinib treatment efficiently delays biochemical-only recurrent ovarian cancer progression
by: Zhongyu Wang, et al.
Published: (2021-07-01)

Efficacy and safety of apatinib in the treatment of osteosarcoma: a single-arm meta-analysis among Chinese patients
by: Hui Yao, et al.
Published: (2021-04-01)

Clinical Observation of Apatinib in Treatment of Refractory Advanced Breast Cancer
by: WANG Jing, et al.
Published: (2020-11-01)

Efficacy and safety of sorafenib versus apatinib in the treatment of intermediate and advanced hepatocellular carcinoma: a comparative retrospective study
by: Wang Y, et al.
Published: (2018-06-01)

The Efficacy and Safety of Apatinib in Advanced Synovial Sarcoma: A Case Series of Twenty-One Patients in One Single Institution
by: Wang Y, et al.
Published: (2020-07-01)

The efficacy and safety of apatinib in Ewing’s sarcoma: a retrospective analysis in one institution
by: Wang Y, et al.
Published: (2018-12-01)

The Safety and Efficacy of Camrelizumab and Its Combination With Apatinib in Various Solid Cancers
by: Kunlun Wang, et al.
Published: (2020-10-01)

A Phase II, Single-Arm Study of Apatinib and Oral Etoposide in Heavily Pre-Treated Metastatic Breast Cancer
by: Nanlin Hu, et al.
Published: (2021-02-01)

Management of Apatinib-Related Adverse Events in Patients With Advanced Osteosarcoma From Four Prospective Trials: Chinese Sarcoma Study Group Experience
by: Lu Xie, et al.
Published: (2021-07-01)

Cannot write session to /tmp/vufind_sessions/sess_jd3havqn5ce2iq6hjuu0fdf2g7